{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T05:57:47Z","timestamp":1790575067283,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12831-6","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T05:50:19Z","timestamp":1790574619000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of miR-199a-3p and CDK7 expression with clinicopathological features of breast cancer"],"prefix":"10.1007","volume":"53","author":[{"given":"Noralhuda Ayad","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazha Jamal","family":"Hidayat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"issue":"7","key":"12831_CR1","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1002\/cncr.32648","volume":"126","author":"AM Afifi","year":"2020","unstructured":"Afifi AM et al (2020) Causes of death after breast cancer diagnosis: A US population-based analysis. Cancer 126(7):1559\u20131567","journal-title":"Cancer"},{"issue":"4","key":"12831_CR2","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.prro.2023.12.003","volume":"14","author":"D Moore-Palhares","year":"2024","unstructured":"Moore-Palhares D et al (2024) Locoregional ablative radiation therapy for patients with breast cancer unsuitable for surgical resection. Practical Radiation Oncol 14(4):316\u2013327","journal-title":"Practical Radiation Oncol"},{"key":"12831_CR3","doi-asserted-by":"publisher","first-page":"110060","DOI":"10.1016\/j.radonc.2023.110060","volume":"195","author":"O Kaidar-Person","year":"2024","unstructured":"Kaidar-Person O et al (2024) Essential requirements for reporting radiation therapy in breast cancer clinical trials: An international multi-disciplinary consensus endorsed by the European Society for Radiotherapy and Oncology (ESTRO). Radiother Oncol 195:110060","journal-title":"Radiother Oncol"},{"issue":"2","key":"12831_CR4","doi-asserted-by":"publisher","first-page":"100364","DOI":"10.1016\/j.apjon.2023.100364","volume":"11","author":"Y Ma","year":"2024","unstructured":"Ma Y et al (2024) Symptom experience in endocrine therapy for breast cancer patients: A qualitative systematic review and meta-synthesis. Asia-Pacific J Oncol Nurs 11(2):100364","journal-title":"Asia-Pacific J Oncol Nurs"},{"key":"12831_CR5","doi-asserted-by":"crossref","unstructured":"Michaels E, Chen N, Nanda R (2024) The role of immunotherapy in triple-negative breast cancer (TNBC). Clinical Breast Cancer","DOI":"10.1016\/j.clbc.2024.03.001"},{"issue":"2","key":"12831_CR6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3390\/cells13020155","volume":"13","author":"T Zakic","year":"2024","unstructured":"Zakic T et al (2024) Breast cancer: mitochondria-centered metabolic alterations in tumor and associated adipose tissue. Cells 13(2):155","journal-title":"Cells"},{"key":"12831_CR7","doi-asserted-by":"crossref","unstructured":"Iweala EEJ, Amuji DN, Nnaji FC (2024) Protein biomarkers for diagnosis of breast cancer. Scientific African 25: p. e02308","DOI":"10.1016\/j.sciaf.2024.e02308"},{"key":"12831_CR8","doi-asserted-by":"publisher","first-page":"1374821","DOI":"10.3389\/fonc.2024.1374821","volume":"14","author":"T Baylie","year":"2024","unstructured":"Baylie T et al (2024) The role of miRNAs as biomarkers in breast cancer. Front Oncol 14:1374821","journal-title":"Front Oncol"},{"key":"12831_CR9","doi-asserted-by":"crossref","unstructured":"Yadav P et al (2024) MicroRNA-mediated regulation of nonsense-mediated mRNA decay factors: Insights into microRNA prediction tools and profiling techniques. Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms 1867 (2): p. 195022","DOI":"10.1016\/j.bbagrm.2024.195022"},{"key":"12831_CR10","doi-asserted-by":"crossref","unstructured":"Hou Z et al (2024) A sensitive one-pot ROA assay for rapid miRNA detection. aBIOTECH 5 (3): p. 1\u20131","DOI":"10.1007\/s42994-024-00140-0"},{"issue":"1","key":"12831_CR11","doi-asserted-by":"publisher","first-page":"e2146","DOI":"10.1002\/biof.2146","volume":"51","author":"S Kumar","year":"2025","unstructured":"Kumar S, Ranga A (2025) Role of miRNAs in breast cancer development and progression. Curr Res BioFactors 51(1):e2146","journal-title":"Curr Res BioFactors"},{"key":"12831_CR12","doi-asserted-by":"crossref","unstructured":"Zhang S et al (2021) The risks of miRNA therapeutics: in a drug target perspective. Drug design, development and therapy 15: p. 721\u201373","DOI":"10.2147\/DDDT.S288859"},{"key":"12831_CR13","doi-asserted-by":"publisher","first-page":"1333563","DOI":"10.3389\/fimmu.2024.1333563","volume":"15","author":"N Abolhasanzadeh","year":"2024","unstructured":"Abolhasanzadeh N et al (2024) Exploring the intricate relationship between miRNA dysregulation and breast cancer development: insights into the impact of environmental chemicals. Front Immunol 15:1333563","journal-title":"Front Immunol"},{"key":"12831_CR14","doi-asserted-by":"crossref","unstructured":"Meng W et al (2022) miR-199a: A Tumor Suppressor with Noncoding RNA Network and Therapeutic Candidate in Lung Cancer. Int J Mol Sci 23(15) : p. 8518","DOI":"10.3390\/ijms23158518"},{"issue":"10","key":"12831_CR15","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41389-020-00282-y","volume":"9","author":"Z Li","year":"2020","unstructured":"Li Z et al (2020) microRNA-199a-3p inhibits hepatic apoptosis and hepatocarcinogenesis by targeting PDCD4. Oncogenesis 9(10):95","journal-title":"Oncogenesis"},{"issue":"24","key":"12831_CR16","doi-asserted-by":"publisher","first-page":"5383","DOI":"10.1158\/1078-0432.CCR-22-1206","volume":"28","author":"NS Meagher","year":"2022","unstructured":"Meagher NS et al (2022) Gene-expression profiling of mucinous ovarian tumors and comparison with upper and lower gastrointestinal tumors identifies markers associated with adverse outcomes. Clin Cancer Res 28(24):5383\u20135395","journal-title":"Clin Cancer Res"},{"issue":"2","key":"12831_CR17","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s10549-022-06533-3","volume":"193","author":"NH To","year":"2022","unstructured":"To NH et al (2022) Radiation therapy for triple-negative breast cancer: emerging role of microRNAs as biomarkers and radiosensitivity modifiers. A systematic review. Breast Cancer Res Treat 193(2):265\u2013279","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"12831_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/mmr.2021.11943","volume":"23","author":"H Xiong","year":"2021","unstructured":"Xiong H et al (2021) MicroRNA\u2013199a\/b\u20135p inhibits endometrial cancer cell metastasis and invasion by targeting FAM83B in the epithelial\u2013to\u2013mesenchymal transition signaling pathway. Mol Med Rep 23(5):1\u201310","journal-title":"Mol Med Rep"},{"key":"12831_CR19","doi-asserted-by":"crossref","unstructured":"Xiong H et al (2021) MicroRNA\u2013199a\/b\u20135p inhibits endometrial cancer cell metastasis and invasion by targeting FAM83B in the epithelial\u2013to\u2013mesenchymal transition signaling pathway. Mol Med Rep 23(5) : p. 304","DOI":"10.3892\/mmr.2021.11943"},{"issue":"37","key":"12831_CR20","doi-asserted-by":"publisher","first-page":"22849","DOI":"10.1073\/pnas.2009627117","volume":"117","author":"BJ Greber","year":"2020","unstructured":"Greber BJ et al (2020) The cryoelectron microscopy structure of the human CDK-activating kinase. Proc Natl Acad Sci U S A 117(37):22849\u201322857","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"12831_CR21","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1080\/13543776.2023.2195547","volume":"33","author":"M Kovalov\u00e1","year":"2023","unstructured":"Kovalov\u00e1 M et al (2023) A patent review of cyclin-dependent kinase 7 (CDK7) inhibitors (2018\u20132022). Expert Opin Ther Pat 33(2):67\u201387","journal-title":"Expert Opin Ther Pat"},{"issue":"1","key":"12831_CR22","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s12964-024-01577-y","volume":"22","author":"Y Gong","year":"2024","unstructured":"Gong Y, Li H (2024) CDK7 in breast cancer: mechanisms of action and therapeutic potential. Cell Communication Signal 22(1):226","journal-title":"Cell Communication Signal"},{"issue":"6Supplement","key":"12831_CR23","doi-asserted-by":"publisher","first-page":"5712","DOI":"10.1158\/1538-7445.AM2024-5712","volume":"84","author":"H Jung","year":"2024","unstructured":"Jung H et al (2024) Functional dissection of CDK7 in transcription using a highly selective CDK7 inhibitor Q901. Cancer Res 84(6Supplement):5712\u20135712","journal-title":"Cancer Res"},{"key":"12831_CR24","doi-asserted-by":"publisher","first-page":"1390704","DOI":"10.3389\/fcell.2024.1390704","volume":"12","author":"AS Abdul Manap","year":"2024","unstructured":"Abdul Manap AS et al (2024) Mapping the function of MicroRNAs as a critical regulator of tumor-immune cell communication in breast cancer and potential treatment strategies. Front Cell Dev Biol 12:1390704","journal-title":"Front Cell Dev Biol"},{"issue":"10","key":"12831_CR25","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1002\/iub.1433","volume":"67","author":"SQ Li","year":"2015","unstructured":"Li SQ et al (2015) MiR-199a\/b-3p suppresses migration and invasion of breast cancer cells by downregulating PAK4\/MEK\/ERK signaling pathway. IUBMB Life 67(10):768\u2013777","journal-title":"IUBMB Life"},{"issue":"3","key":"12831_CR26","first-page":"2021","volume":"14","author":"JC Ho","year":"2022","unstructured":"Ho JC et al (2022) MicroRNA-199a-3p promotes drug sensitivity in triple negative breast cancer by down-regulation of BRCA1. Am J Transl Res 14(3):2021\u20132036","journal-title":"Am J Transl Res"},{"key":"12831_CR27","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.biopha.2017.01.058","volume":"88","author":"X Fan","year":"2017","unstructured":"Fan X et al (2017) MiR-199a-3p enhances breast cancer cell sensitivity to cisplatin by downregulating TFAM (TFAM). Biomed Pharmacother 88:507\u2013514","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"12831_CR28","doi-asserted-by":"publisher","first-page":"7724","DOI":"10.1080\/21655979.2021.1982324","volume":"12","author":"Z Jin","year":"2021","unstructured":"Jin Z, Jiang S (2021) Long non-coding RNA TTN-AS1\/microRNA-199a-3p\/runt-related transcription factor 1 gene axis regulates the progression of oral squamous cell carcinoma. Bioengineered 12(1):7724\u20137736","journal-title":"Bioengineered"},{"key":"12831_CR29","doi-asserted-by":"publisher","first-page":"620214","DOI":"10.3389\/fonc.2021.620214","volume":"11","author":"S Saha","year":"2021","unstructured":"Saha S, Dey S, Nath S (2021) Steroid Hormone Receptors: Links With Cell Cycle Machinery and Breast Cancer Progression. Front Oncol 11:620214","journal-title":"Front Oncol"},{"issue":"2","key":"12831_CR30","doi-asserted-by":"publisher","first-page":"669","DOI":"10.21037\/tcr-20-2911","volume":"10","author":"L Tang","year":"2021","unstructured":"Tang L et al (2021) Expression of CDK7 correlates with molecular subtypes and predicts clinical outcomes in breast cancer. Transl Cancer Res 10(2):669\u2013680","journal-title":"Transl Cancer Res"},{"issue":"1","key":"12831_CR31","first-page":"32","volume":"12","author":"R Huang","year":"2020","unstructured":"Huang R et al (2020) The activation of GPER inhibits cells proliferation, invasion and EMT of triple-negative breast cancer via CD151\/miR-199a-3p bio-axis. Am J Translational Res 12(1):32","journal-title":"Am J Translational Res"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12831-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12831-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12831-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T05:50:20Z","timestamp":1790574620000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12831-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12831"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12831-6","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"assertion":[{"value":"10 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study received ethics approval, and it was carried out according to the standards of Salahaddin University\u2019s Ethics Committee (approved no. 45\/322; 2024), and the study was conducted according to the principles of the Declaration of Helsinki. All enrolled patients signed informed consent forms.","order":2,"name":"Ethics","label":"Ethical committee and consent for participation","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1650"}}